ATM and neoplasm: While the presence of high frequencies of TERT promoter mutations in metastatic PTCs was already demonstrated to be associated with tumor aggressiveness [14–16], the enrichment of ATM pathogenic mutations in the LNMs of PTC patients with 4 or more DMs observed in this study is noteworthy.